Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Whole-Breast Irradiation Preceded by Intra-Operative Radiotherapy With Electrons as Anticipated Boost HIOB A New Option in Breast-Conserving Treatment for Operated Breast Cancer Stages I and II

NCT01343459 is registered in ClinicalTrials.gov with Paracelsus Medical University as lead sponsor.

NCT NCT01343459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Whole-Breast Irradiation Preceded by Intra-Operative Radiotherapy With Electrons as Anticipated Boost HIOB A New Option in Breast-Conserving Treatment for Operated Breast Cancer Stages I and II
Lead sponsor
Paracelsus Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2022
Enrollment
1,464 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

local neoplasm recurrence, toxicity